Allergy Therapeutics PLC Holding(s) in Company (7858H)
December 02 2015 - 10:47AM
UK Regulatory
TIDMAGY
RNS Number : 7858H
Allergy Therapeutics PLC
02 December 2015
For filings with the FCA include
the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer or the Allergy Therapeutics PLC
underlying issuer of existing shares
to which voting rights are attached:
(ii)
-------------------------------------- -------------------------
2 Reason for the notification (please tick the appropriate box
or boxes):
-------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------------- ------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
----------------------------------------------------------------- ------
An acquisition or disposal of instruments with similar
economic effect to qualifying financial instruments
----------------------------------------------------------------- ------
An event changing the breakdown of voting rights
----------------------------------------------------------------- ------
Other (please
specify):
----------------- ---------------------------------------------- ------
3. Full name of person(s) subject SOUTHERN FOX INVESTMENTS LTD.
to the notification obligation:
(iii)
------------------------------------ ------------------------------
4. Full name of shareholder(s) CHASE NOMINEES LTD -CMBLJPPB
(if different from 3.): (iv)
------------------------------------ ------------------------------
5. Date of the transaction and date 17(th) November, 2015
on which the threshold is crossed
or reached: (v)
------------------------------------ ------------------------------
6. Date on which issuer notified: 2(nd) December, 2015
------------------------------------ ------------------------------
7. Threshold(s) that is/are crossed Over 21.66%
or
reached: (vi, vii)
------------------------------------ ------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- -------------------------- -----------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
--------------- ------------ ------------ ------------ ----------------------- --------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ------------ ------------ ------------ ------------ --------- --------- ---------
Ord GBP 0.01
GB00B02LCQ05 125,348,783 125,348,783 127,133,783 127,133,783 21.66%
--------------- ------------ ------------ ------------ ------------ --------- --------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion rights that rights
Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
------------------ ------------- -------------- ----------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
127,133,783 21.66%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
---------------------------------------------------------------------------
Proxy Voting:
----------------------------------------------------------------
10. Name of the proxy holder: SOUTHERN FOX INVESTMENTS
LTD
------------------------------------ --------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------ --------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------ --------------------------
13. Additional information:
------------------------------- -------------------
14. Contact name: George O' Carroll
------------------------------- -------------------
15. Contact telephone number: +353-61-472019
------------------------------- -------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUSVRVVAURAA
(END) Dow Jones Newswires
December 02, 2015 10:47 ET (15:47 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
